Jonathan Jackson represents Illinois's 1st Congressional District, sits on the House Agriculture Committee, and has been turning up on panels about voting rights and reproductive access. He's also been quietly moving money through his disclosure filings at a pace of eight trades in the last 90 days. None of those things are necessarily connected. But the public record has a way of arranging details into a picture, and the picture here is worth a look.
The Panel Circuit, and What Else He's Been Up To
Recent social chatter about Jackson has been low-volume but specific. He appeared at a Congressional Black Caucus Foundation Policy Summit panel. He joined a podcast to talk about voting rights. He was cited in a thread about birth control access and the Griswold anniversary. Three posts on Bluesky in the last 24 hours, all of them framing him as a progressive voice on civil liberties.
That's the public-facing version of Jonathan Jackson. The disclosure-filing version has been busier in a different way.
Eight trades filed in 90 days. Purchases in BP and Procter & Gamble. Sales in Tenet Healthcare, O'Reilly Automotive, and Visa. The activity is not unusual by congressional standards, but a few items earn a second look.
The Visa Sale and the Banking Bills He Skipped
On April 24, Jackson's disclosure record shows a sale of Visa (V) in the $50,000-00,000 range. That's the largest single transaction in his recent 90-day window.
Then on May 20, the House passed four pieces of legislation with direct financial-sector relevance: the American Access to Banking Act, the Community Bank Deposit Access Act of 2025, the Keeping Deposits Local Act, and the Fiscal Year 2025 Veterans Affairs Major Medical Facility Authorization Act. Jackson's recorded position on all four: Not Voting.
The Visa sale and the absences sit about 26 days apart. The trade alpha data shows the Visa sale generated a 30-day alpha of -0.3 percent, meaning it barely moved against the S&P 500 in the month after he sold. So on the financial-performance ledger, this was not a brilliant exit. What makes it notable is different.
Jackson's committee assignments are Agriculture and Foreign Affairs. Banking regulation is not his committee's beat. The brief flags the Visa trade as carrying a "Financial Services" committee overlap in the alpha record's own notation, which is worth flagging even if the overlap is administrative rather than jurisdictional in Jackson's case. He's not on Financial Services. He doesn't oversee Visa's sector from a committee perch. The calendar proximity between the sale and the banking-bill votes is the thing here, not any claim about what information he had or when he received it.
Members are required to disclose. They are not required to divest, recuse, abstain, blush, or look up from their phones.
The Full Trade Picture: 48-for-97
Pull back from the Visa sale and the broader record is less dramatic. Jackson has 97 scored trades in the Blind Trust database. Forty-eight came out positive on 30-day alpha. Forty-nine did not. His mean 30-day alpha across all 97 trades is essentially zero: -0.0 percent.
He's not beating the market. He's also not obviously losing it. He's running at roughly coin-flip accuracy, which is what most congressional portfolios look like when you score the whole sample and not just the highlight reel.
The highlight reel, for what it's worth, looks like this: a September 2025 purchase of Robinhood (HOOD) at K-5K that logged a 43.2 percent 30-day alpha. A January 2026 purchase of GE Vernova (GEV) at 5K-$50K that returned 21.1 percent above the index in 30 days. A META purchase in April 2025 that beat the S&P by 17 points in a month.
None of those have committee overlap. They're just trades that worked.
The flip side is real too. He sold Palantir (PLTR) in January 2026 in the 5K-$50K range and that sale generated -21.7 percent alpha: meaning Palantir kept climbing after he got out. He sold Doximity (DOCS) in November 2025 and that cost him -23.2 percent in relative terms. He sold Robinhood again in January 2026, after buying it profitably in September, and that exit cost him -29.5 percent against the index. He bought it right, sold it wrong.
The honest version of the Jackson alpha record is: 48 wins, 49 losses, flat on average. The wins look smart when you read them alone. The full 97-trade sample is a wash.
The Recent 90 Days in Order
Here's what the disclosures show from March 19 through April 24:
- March 19: Purchased BP at 5K-$50K. Sold O'Reilly Automotive (ORLY) at 5K-$50K.
- March 20: Purchased BP again at K-5K. Two consecutive days building a BP position worth up to $65,000 combined.
- April 15: Sold Tenet Healthcare (THC) at K-5K.
- April 20: Purchased Procter & Gamble (PG) at 5K-$50K. Sold Tenet Healthcare again at 5K-$50K. He's been unwinding THC in two tranches.
- April 24: Sold O'Reilly Automotive at K-5K. Sold Visa at $50K-00K.
The BP accumulation is the most structurally interesting piece. Two purchases on back-to-back days. Jackson sits on the House Agriculture Committee, specifically the Commodity Markets, Digital Assets, and Rural Development subcommittee, and the Nutrition and Foreign Agriculture subcommittee. BP is an integrated oil major. The Agriculture Committee's commodity markets remit touches energy commodities in ways that are not entirely clean, though BP's equity price is more directly tied to oil markets and global supply than to anything Jackson's subcommittee would be marking up. The overlap here is ambient, not direct.
The Tenet Healthcare exits are a different texture. Tenet (THC) is a hospital chain. Jackson's committees don't cover healthcare. He sold in two tranches over five days, clearing up to $65,000 in a position. No obvious committee peg. Just a member trimming a healthcare holding.
The Votes He Showed Up For, and the Ones He Didn't
The May 20 floor session was dense with financial legislation. Jackson missed the American Access to Banking Act and the Community Bank Deposit Access Act of 2025, both of which passed. He also missed the Keeping Deposits Local Act. On May 21, he voted Nay on the Veterans 2nd Amendment Protection Act and the Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act, both of which passed over his objection.
Four absences on a single day of banking bills, a month after the largest trade in his recent window. The absence could mean anything: travel, a constituent event, illness, a scheduling conflict. Congressional attendance is notoriously variable, and a single day of absences doesn't build a pattern by itself.
What it does is sit next to the Visa sale on the same page of the public record, and the public record doesn't caption its own photos.
The Context He's Building in Public
The panel appearances and podcast bookings tell you what Jackson wants his political brand to look like: civil rights, voting access, reproductive rights. The Griswold anniversary thread. The CBC Foundation summit. These are intentional signals about where he's planting his flag as a member from a safe Democratic seat.
The financial disclosures are a different kind of signal, and they're not ones he's curating. They just show up in the database: BP in March, Procter & Gamble in April, Visa out the door in the $50K-00K range, a coin-flip record across 97 trades that neither indicts him nor clears him of anything, because the record is not a verdict.
His full trading history is public at Blind Trust. The roll-call shows four absences on May 20. The disclosures show the Visa sale on April 24. The math on his alpha record is 48 of 97, mean zero.
The receipts are public. Make of them what you make of them.